Halozyme Therapeutics, Inc.

HALO·NASDAQ·$68.72Share Price as of 11/2·$8BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/11/26 10-KFY 202502/17/26 10-QQ3 ended 09/30/2511/03/25 10-QQ2 ended 06/30/2508/05/25

Disclosures

8-KCurrent report09/30/26 8-KCurrent report09/22/26 8-KCurrent report09/18/26 8-KCurrent report09/16/26 8-KCurrent report08/18/26

Prospectuses and Registrations

S-8Registration of securities for employees11/18/25 S-8Registration of securities for employees05/05/21 S-8Registration of securities for employees05/05/21 S-8 POSPost-effective amendment (S-8)05/14/19 S-8 POSPost-effective amendment (S-8)05/14/19

Proxies

DEF 14ADefinitive proxy03/23/26 DEFA14AAdditional proxy materials03/23/26 DEF 14ADefinitive proxy03/18/25 DEFA14AAdditional proxy materials03/18/25 DEF 14ADefinitive proxy03/15/24

Ownership

Form 4Insider transaction10/08/26 4/AInsider transaction (amended)10/08/26 Form 3Initial insider ownership10/02/26 Form 4Insider transaction10/02/26 Form 4Insider transaction10/02/26

Other

ARSAnnual report to shareholders03/23/26 ARSAnnual report to shareholders03/18/25 ARSAnnual report to shareholders03/15/24 UPLOADLetter from the SEC07/21/23 CORRESPCorrespondence with the SEC06/28/23